McDermott + Bull Partner Ken Dropiewski sits down with KCK Group’s Senior Managing Director Greg Garfield to explore essential topics for investors in the MedTech space. Greg provides an inside look at KCK Group’s typical investment and team structure, as...
McDermott + Bull has successfully placed Michael Selberis as Chief Technology Officer at ClinNEXUS. Michael will lead the development and execution of ClinNEXUS’s technology strategy, overseeing all aspects of technological direction to ensure alignment with the...
McDermott + Bull has successfully placed Courtney Walton as Vice President of Quality & Regulatory at Natus Neuro. Courtney will be reporting directly to the Chief Executive Officer and will lead the company’s efforts to achieve and maintain excellence in quality...
What a difference a year makes. In the first half of 2024, the MedTech sector showed a notable uptick in M&A activity, with 114 acquisitions valued at $40.3 billion — close to last year’s total. Despite fewer venture rounds, funding remained strong at $9.7...
McDermott + Bull Partner Ken Dropiewski sits down with Lightstone Ventures General Partner Mike Carusi to explore essential topics for CEOs and investors. Mike provides an inside look at Lightstone Ventures’ focus areas and shares his perspective on current...
McDermott + Bull has successfully placed Lisa Henry as Vice President, Clinical and Regulatory at Magenta Medical. Reporting to the CEO, Lisa will lead the clinical and regulatory strategies critical to Magenta’s success. As the first U.S.-based team member, Lisa will...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
